Skip to main content
Article thumbnail
Location of Repository

Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds

By Giulia Matusali, Giuseppe Arena, Alessandra De Leo, Livia Di Renzo and Elena Mattia
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2657105
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1986). A: Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. Embo J
    2. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.
    3. (1990). AJ: Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell
    4. (2001). Allday MJ: Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
    5. (1989). An intricate route to immortality. Cell
    6. (1993). Baeuerle PA: Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus. Embo J
    7. (1999). D'Erme M: Interactions of Epstein-Barr Virus Origins of Replication with Nuclear Matrix in the Latent and in the Lytic Phases of Viral Infection. Virology
    8. (2002). E: Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBVtransformed B lymphocytes. Oncogene
    9. (1988). E: Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.
    10. (1993). E: Induction of the lytic viral cycle in Epstein Barr virus carrying Burkitt lymphoma lines is accompanied by increased expression of major histocompatibility complex molecules. Immunol Lett
    11. (2007). E: LMP1 TRAFficking activates growth and survival pathways. Adv Exp Med Biol
    12. (2001). Epstein Barr Virus
    13. (2008). Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol Cell Biochem
    14. (1996). Expression of the Epstein Barr Virus Transforming
    15. (2004). High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells.
    16. (1979). Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology
    17. (1993). Ischiropoulos H: Evaluation of 2',7'-Dichlorofluorescin and
    18. (1999). Klyubin IV: Roles of reactive oxygen species: signaling and regulation of cellular functions. Int Rev Cytol
    19. (2003). Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.
    20. (1999). LS: Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production.
    21. (2007). Mattia E: Inhibition of Poly(ADPribose)polymerase impairs Epstein Barr Virus lytic cycle progression. Infect Agent Cancer
    22. (2004). Oxygen free radicals and redox biology of organelles. Histochem Cell Biol
    23. (1988). PJ: Sequence analysis of Raji Epstein-Barr virus DNA. Virology
    24. (1996). Raab-Traub N: Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.
    25. (1998). Raab-Traub N: Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.
    26. (2005). Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. PNAS
    27. (2001). Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem
    28. (2005). Regulation of Survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines. Cell Res
    29. (1991). Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell
    30. (1992). Rickinson AB: Epstein-Barr virus infection and replication in a human epithelial cell system. Nature
    31. (1994). Rickinson AB: Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.
    32. (2004). Sairenji T: Inhibition of Epstein-Barr virus (EBV) reactivation by short interfering RNAs targeting p38 mitogen-activated protein kinase or c-myc in EBV-positive epithelial cells.
    33. (2000). Sato H: Transformation of MadinDarby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene
    34. (2002). Signaling and proapoptotic functions of transformed cell-derived reactive oxygen species. Prostaglandins Leukot Essent Fatty Acids
    35. (2003). Sugden B: CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal
    36. (2003). Sun R: NF-kappaB inhibits gammaherpesvirus lytic replication.
    37. (2005). Susin SA: Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc)
    38. (1989). Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.
    39. (2005). Takada K: Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production.
    40. (1998). Takada K: The truncated form of the Epstein-Barr virus LMP-1 is dispensable or complimentable by the full-length form in virus infection and replication. Virology
    41. (2000). The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene
    42. (1989). The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.
    43. (1986). Y: trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.
    44. (2004). Yamamoto K: DNA damage responses to oxidative stress. DNA Repair (Amst)
    45. (2001). Young LS: LMP1 structure and signal transduction. Semin Cancer Biol

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.